Alerts will be sent to your verified email
Verify Email
ALKEM
|
Alkem Laboratories
|
Abbott India
|
Aurobindo Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.38 % | 30.11 % | 12.72 % |
|
5yr Avg Net Profit Margin
|
14.54 % | 18.53 % | 12.5 % |
|
Price to Book
|
5.29 | 16.1 | 1.82 |
|
P/E
|
27.73 | 46.93 | 17.56 |
|
5yr Avg Cash Conversion Cycle
|
-61.46 Days | -46.68 Days | -46.37 Days |
|
5yr Average Interest Coverage Ratio
|
24.48 | 97.37 | 43.54 |
|
5yr Avg ROCE
|
22.76 % | 38.77 % | 15.27 % |
|
5yr Avg Operating Profit Margin
|
18.44 % | 23.42 % | 19.22 % |
|
5 yr average Debt to Equity
|
0.18 | 0.0 | 0.19 |
|
5yr CAGR Net Profit
|
6.44 % | 15.41 % | -8.16 % |
|
5yr Average Return on Assets
|
12.47 % | 21.03 % | 8.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.04 % | 74.99 % | 51.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 17.08 % |
|
Change in Promoter Holding (3 Yrs)
|
-4.1 % | 0.0 | -0.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
8.82 % | 2.93 % | 9.14 % |
|
Alkem Laboratories
|
Abbott India
|
Aurobindo Pharma
|
|---|